Blinatumomab Monoclonal Antibody from China
Blinatumomab is a bispecific T-cell engager (BiTE) monoclonal antibody used for the treatment of acute lymphoblastic leukemia. As an unmixed biotechnological product not put up in measured doses or retail sale forms, it is classified under tariff item 3002.13.00.
Duty Rate — China → Canada
0%
Import Tips
• Document the product's biotechnological origin and confirm it is not mixed with any additives
• Ensure the import is not in retail packaging, as that would change the tariff classification
• Consult the CBSA's advance ruling process for certainty on classification